Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent Biosolutions (NY: EBS ) 6.820 -0.160 (-2.29%) Official Closing Price Updated: 7:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Emergent Biosolutions < Previous 1 2 3 4 5 6 7 8 9 Next > White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know June 29, 2022 Via Benzinga U.S. FDA Accepts Emergent's Anthrax Vaccine Candidate Filing For Review June 24, 2022 The U.S. Food and Drug Administration (FDA) has accepted to review Emergent BioSolutions’ (NYSE: EBS) Biologics License Application (BLA) for its new anthrax vaccine candidate AV7909. The regulatory... Via Benzinga 7 Penny Stocks That Could Triple in 2022 June 22, 2022 Penny stocks are affordable and some with credible business models in all likelihood have the potential to generate superior returns. Via InvestorPlace 7 No-Brainer Biotech Stocks to Add to Your Buy List June 09, 2022 With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. Via InvestorPlace 7 Monkeypox Stocks That May Take Off in Q2 June 09, 2022 SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. Via InvestorPlace Morning Brief: Top Financial Stories Dominating on Tuesday, June 7 June 07, 2022 Reuters Via Benzinga J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement June 07, 2022 Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS). Via Benzinga Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract June 06, 2022 Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines. Via Benzinga Monkeypox Outbreak Puts Focus On These Two Biotechs May 27, 2022 Just when you thought it was safe to go outside, monkeypox pops up. Still, this might not be bad news for the market, as the world will turn once again to vaccine makers to find a solution. Via Talk Markets 7 Monkeypox Stocks to Watch Right Now May 24, 2022 Wondering what are the best monkeypox stocks to watch? Here are the companies producing vaccines to help fight the spread of the virus. Via InvestorPlace Morning Brief: Top Financial Stories Dominating on Tuesday, May 24 May 24, 2022 CNBC Via Benzinga WHO Says Monkeypox Outbreak 'Unusual' But 'Containable' May 24, 2022 The World Health Organization (WHO) said that there had been 131 confirmed monkeypox cases and 106 further suspected cases, Via Benzinga Why Emergent Biosolutions Stock Is Rising Today May 23, 2022 Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Monday amid increasing monkeypox concerns. Via Benzinga 24 Stocks Moving in Monday's Pre-Market Session May 23, 2022 Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday. Via Benzinga 6 Stocks To Watch Amid Monkeypox Outbreak May 20, 2022 A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. Via Benzinga Stock Market Recap: This Week’s 5 Top Stories May 20, 2022 It's been a busy week for the stock market and we're going over all the latest news that investors need to know about with a recap! Via InvestorPlace Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments May 20, 2022 Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox. Via InvestorPlace 71 Biggest Movers From Yesterday May 20, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 19, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... Via Benzinga What Is Monkeypox Virus That Is Spreading in Europe, US May 19, 2022 Monkeypox was first discovered in the late 1950s after cropping up among monkeys kept for research. Like smallpox and chickenpox, it is characterized by flu-like symptoms and pus-filled blisters and... Via Benzinga 73 Biggest Movers From Yesterday May 17, 2022 Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. Via Benzinga Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3% May 16, 2022 U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday. Via Benzinga Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge May 16, 2022 U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday. Via Benzinga 41 Stocks Moving In Monday's Mid-Day Session May 16, 2022 Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. Via Benzinga Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points May 16, 2022 U.S. stocks traded lower this morning, with the Nasdaq Composite adding more than 400 points on Friday. Via Benzinga 7 High-Risk, High-Reward Small-Cap Stocks to Buy Now May 13, 2022 Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards. Via InvestorPlace Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco May 11, 2022 Via Benzinga Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements April 29, 2022 Via Benzinga 5 Value Stocks In The Healthcare Sector April 25, 2022 What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China March 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.